Three common medicines classified as carcinogenic by WHO cancer agency
The WHO's cancer agency, IARC, has classified three common medications—hydrochlorothiazide, voriconazole, and tacrolimus—as Group 1 carcinogens. Health experts emphasize that this is a hazard identification and patients should not stop their medication without medical consultation.
Three widely-prescribed medicines used to treat high blood pressure, fungal infections, and organ transplant rejection have been classified as “carcinogenic to humans” (Group 1) by the International Agency for Research on Cancer (IARC), the World Health Organisation’s (WHO) cancer research agency. Experts stressed that the classification is a hazard identification and should not prompt patients to discontinue treatment without consulting their doctors.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in